SEARCH
A1c-Cellular is a whole blood control that tests the entire HbA1c procedure including red blood cell lysis, a step that is not evaluated by competitor controls. Designed to resemble a patient sample, A1c-Cellular does not need to be reconstituted prior to use, reducing the potential for human error.
This control is packaged in convenient vials with pierceable caps for autosampling and is available in two clinically significant levels. A1c-Cellular is appropriate for immunoassay and ionic exchange HPLC methodologies and is assayed on the top HbA1c chemistry analyzers.
Available in two clinically significant levels
Appropriate for immunoassay and ionic exchange HPLC methodologies
Assayed on the top HbA1c analyzers
30-day open-vial stability; 190-day closed-vial stability
Tests the entire process including the lysis step
Does not need to be reconstituted, reducing the potential for human error
Access to STATS®, our free interlaboratory quality control program for peer group data comparison
| Description | Item Number |
|---|---|
| 2 x 2.0 mL (Level 1 & 2) | 211130 |
| 6 x 2.0 mL (Level 1 & 2) | 211124 |
A1c-Cellular is a whole blood control that tests the entire HbA1c procedure including red blood cell lysis. Designed to resemble a patient sample, A1c-Cellular contains intact red blood cells and does not need to be reconstituted prior to use, reducing the potential for human error.
A1c-Cellular is the only HbA1c control that includes the critical step of lysing the RBCs. Competitor controls use reconstituted hemoglobin that bypasses the lysis step, meaning they cannot detect problems with reagent lysis buffers or instrument lysis procedures. A1c-Cellular evaluates the entire HbA1c analysis process from instrument to reagents to ensure accurate patient results.
A1c-Cellular is appropriate for both immunoassay and ionic exchange HPLC methodologies. The control is assayed on the top HbA1c analyzers, ensuring broad compatibility across different testing platforms and technologies.
No, A1c-Cellular is a ready-to-use whole blood control that does not need to be reconstituted prior to use. This eliminates preparation steps that can introduce variability and human error, simplifying the quality control workflow and ensuring consistent performance.
A1c-Cellular is available in two clinically significant levels that span the range of HbA1c values encountered in both diabetic and non-diabetic patients. This allows laboratories to verify instrument and assay performance across the clinically relevant HbA1c concentration range.
A1c-Cellular offers 30-day open-vial stability and 190-day closed-vial stability. This extended shelf life reduces the frequency of shipments and lot-to-lot correlations, saving laboratory time and resources while maintaining consistent quality control performance.
A1c-Cellular is packaged in convenient vials with pierceable caps for autosampling. This design allows the control to be loaded directly onto automated HbA1c analyzers without transferring to secondary containers, reducing the potential for contamination and improving workflow efficiency.
HbA1c testing involves multiple steps: sample handling, red blood cell lysis, hemoglobin extraction and quantification. Errors at any step can compromise results. A1c-Cellular contains intact RBCs that must be lysed properly to release hemoglobin, challenging the complete procedure including reagent performance and instrument lysis function. This comprehensive evaluation ensures that all critical steps are functioning correctly, not just the final measurement step.
Powered by Bioz